NEWS
AIFA – Impact of simplified procedures introduced in 2020 on the negotiation of medicinal products
In October 2020, the ‘Procedura semplificata di prezzo e rimborso per i farmaci equivalenti/biosimilari (generici)’ [Simplified price and...
Webinar Replay: AMNOG impact on European countries?!
Watch our webinar replay : AMNOG impact on European countries?! Dr. Stefan Walzer discussed this issue together with country experts across Europe.
Webinar : What does the Brexit effect mean for UK patient access?
Join our webinar : What does the Brexit effect mean for UK patient access? on march 29 2022.
What changes to NICE’s health technology evaluation are now in effect?
From 1st February 2022, the National Institute for Health and Care Excellence (NICE) will introduce changes that aim to simplify and speed up Health Technology Assessments (HTA).
The new Italian Law on Rare disease : access to orphan drugs, support for research, solidarity fund.
On 27 November 2021, Law No. 175/2021, was published in the Official Journal. This is the first law dedicated exclusively to rare diseases. It’s main objective is the protection of the right to health of those suffering from rare diseases.